pyrazolanthrone has been researched along with Stomach Neoplasms in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (30.00) | 29.6817 |
2010's | 7 (70.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bui, HTT; Kang, D; Kim, SE; Le, NH; Le, QA; Lee, S | 1 |
Bai, PS; Chen, NZ; Da, R; Kong, Y; Ma, JQ; Ma, LQ; Nan, KJ; Qi, XG; Sun, H; Zhao, RM | 1 |
Chen, YC; Ji, H; Shao, JP; Wei, XN; Weng, GB; Ye, XL; Zhao, YR | 1 |
Chen, G; Li, G; Lv, T; Wu, F; Wu, W; Ye, H; Zhi, FC | 1 |
Li, BW; Li, Z; Tang, J; Tao, JQ; Wang, JW; Wang, LJ; Wang, WZ; Wei, S; Xie, KL; Xu, H; Xu, ZK; Yang, L; Zhang, DC; Zhang, Q; Zhi, XF; Zhu, Y | 1 |
Kang, HS; Kim, HS; Kim, JH; Kim, TH; Ro, J; Yoon, S | 1 |
Mishra, P; Rana, B; Rangasamy, V; Senthivinayagam, S; Sondarva, G | 1 |
Chung, KS; Han, G; Kim, BK; Kim, DM; Kim, HM; Lee, K; Oh, YK; Park, SK; Simon, JA; Song, A; Song, KB; Won, KJ; Won, M | 1 |
Chen, JH; Huang, CC; Lin, HH; Wang, CJ | 1 |
Chang, PM; Chen, WC; Chou, CT; Chu, ST; Fang, YC; Huang, CC; Huang, CJ; Jan, CR; Liu, SI; Lu, YC; Wang, BW; Wang, JL | 1 |
10 other study(ies) available for pyrazolanthrone and Stomach Neoplasms
Article | Year |
---|---|
Synergistic apoptosis of human gastric cancer cells by bortezomib and TRAIL.
Topics: Aged; Anthracenes; Apoptosis; Bortezomib; Butadienes; Caspases; Cell Line, Tumor; Cell Survival; Drug Resistance, Neoplasm; Drug Synergism; Female; Gene Expression Regulation, Neoplastic; Humans; Male; MAP Kinase Kinase 4; MAP Kinase Signaling System; Middle Aged; Nitriles; p21-Activated Kinases; Receptors, TNF-Related Apoptosis-Inducing Ligand; Stomach Neoplasms; TNF-Related Apoptosis-Inducing Ligand | 2019 |
Helicobacter pylori promotes invasion and metastasis of gastric cancer cells through activation of AP-1 and up-regulation of CACUL1.
Topics: Adult; Aged; Aged, 80 and over; Animals; Anthracenes; Cell Line, Tumor; Cullin Proteins; Curcumin; Female; Gastric Mucosa; Gene Expression Regulation, Neoplastic; Helicobacter pylori; Humans; Male; Matrix Metalloproteinase 9; Mice; Middle Aged; Neoplasm Invasiveness; Neoplasm Metastasis; Phosphorylation; Promoter Regions, Genetic; Proto-Oncogene Proteins c-fos; Stomach; Stomach Neoplasms; Transcription Factor AP-1; Transcriptional Activation; Up-Regulation; Young Adult | 2013 |
IL-33-induced JNK pathway activation confers gastric cancer chemotherapy resistance.
Topics: Anthracenes; Apoptosis; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Humans; Inflammation; Interleukin-33; MAP Kinase Signaling System; Neoplasm Invasiveness; Stomach Neoplasms | 2015 |
Epigenetic silencing of DUSP9 induces the proliferation of human gastric cancer by activating JNK signaling.
Topics: Anthracenes; Cell Line, Tumor; Cell Proliferation; CpG Islands; DNA Methylation; Dual-Specificity Phosphatases; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Humans; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase Phosphatases; Promoter Regions, Genetic; Stomach Neoplasms | 2015 |
Natriuretic peptide receptor A inhibition suppresses gastric cancer development through reactive oxygen species-mediated G2/M cell cycle arrest and cell death.
Topics: Acetylcysteine; Adenine; Animals; Anthracenes; Atrial Natriuretic Factor; Autophagy; Cell Line, Tumor; Cell Proliferation; Female; G2 Phase Cell Cycle Checkpoints; Gene Expression Regulation, Neoplastic; Humans; Imidazoles; JNK Mitogen-Activated Protein Kinases; Mice; Mice, Nude; Neoplasm Staging; p38 Mitogen-Activated Protein Kinases; Pyridines; Reactive Oxygen Species; Receptors, Atrial Natriuretic Factor; RNA, Small Interfering; Stomach Neoplasms; Tumor Burden; Xenograft Model Antitumor Assays | 2016 |
SP600125, an inhibitor of Jnk pathway, reduces viability of relatively resistant cancer cells to doxorubicin.
Topics: Animals; Anthracenes; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Doxorubicin; Drug Resistance, Neoplasm; Female; Humans; JNK Mitogen-Activated Protein Kinases; Mice; Mitogen-Activated Protein Kinase 8; Protein Kinase Inhibitors; RNA, Small Interfering; Stomach Neoplasms | 2009 |
Mixed lineage kinase-3/JNK1 axis promotes migration of human gastric cancer cells following gastrin stimulation.
Topics: Anthracenes; Blotting, Western; Cell Line, Tumor; Cell Movement; Enzyme Activation; Gastrins; Humans; JNK Mitogen-Activated Protein Kinases; MAP Kinase Kinase Kinases; Matrix Metalloproteinase 7; Mitogen-Activated Protein Kinase 8; Mitogen-Activated Protein Kinase Kinase Kinase 11; Phosphorylation; RNA, Small Interfering; Stomach Neoplasms | 2010 |
Upregulation of RhoB via c-Jun N-terminal kinase signaling induces apoptosis of the human gastric carcinoma NUGC-3 cells treated with NSC12618.
Topics: Anthracenes; Apoptosis; Blotting, Western; Cell Proliferation; E1A-Associated p300 Protein; Flow Cytometry; Humans; JNK Mitogen-Activated Protein Kinases; Luciferases; MAP Kinase Signaling System; Methionine; Piperazines; Promoter Regions, Genetic; Reverse Transcriptase Polymerase Chain Reaction; rhoB GTP-Binding Protein; RNA, Messenger; RNA, Small Interfering; Signal Transduction; Stomach Neoplasms; Tumor Cells, Cultured; Up-Regulation | 2011 |
Apoptotic effect of 3,4-dihydroxybenzoic acid on human gastric carcinoma cells involving JNK/p38 MAPK signaling activation.
Topics: Adenocarcinoma; Anthracenes; Apoptosis; Cell Cycle; Enzyme Inhibitors; Humans; Hydroxybenzoates; Imidazoles; MAP Kinase Kinase 4; MAP Kinase Signaling System; Mitochondria; p38 Mitogen-Activated Protein Kinases; Pyridines; Stomach Neoplasms | 2007 |
Thimerosal-induced apoptosis in human SCM1 gastric cancer cells: activation of p38 MAP kinase and caspase-3 pathways without involvement of [Ca2+]i elevation.
Topics: Anthracenes; Apoptosis; Calcium Signaling; Caspase 3; Cell Line, Tumor; Cell Survival; Chelating Agents; Dose-Response Relationship, Drug; Egtazic Acid; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Flavonoids; Humans; Imidazoles; JNK Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Preservatives, Pharmaceutical; Protein Kinase Inhibitors; Pyridines; Stomach Neoplasms; Thimerosal; Time Factors | 2007 |